Due to the high selective expression of FAP in the tumour microenvironment and its involvement in key processes of tumour growth and survival, it has become an interesting molecular target for the development of cancer therapies and diagnostics in recent years [8,9]. This evidence concerns the gene FAP and neoplasm.